Additionally, to verify that miR-423-5p carried by the CAF-derived exosomes promoted chemotherapy resistance in prostate cancer by targeting GREM2, we selected 22Rv-1/TAX cells for functional rescue experiments. The gene discussed is GREM2; the disease is prostate cancer.